Commit To Buy Navidea Biopharmaceuticals At $2, Earn 28.4% Annualized Using Options
September 03, 2015 at 11:43 AM EDT
Investors considering a purchase of Navidea Biopharmaceuticals, Inc. (NAVB) stock, but tentative about paying the going market price of $2.02/share, might benefit from considering selling puts among the alternative strategies at their disposal..